Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.jaad.org › article › S0190-9622(23)02878-5Guidelines of care for the management of atopic dermatitis in...

   www.jaad.org › article › S0190-9622(23)02878-5

   For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered. Multiple biologic therapies and Janus kinase (JAK)inhibitors have been approved since 2014 to treat AD.

2. www.jacionline.org › article › S0091-6749(23)01112-0Systemic treatments for atopic dermatitis (eczema): Systematic...

   www.jacionline.org › article › S0091-6749(23)01112-0

   5 Σεπ 2023 · When AD is refractory to topical treatments (and potentially other interventions such as dilute bleach baths, 5 allergen immunotherapy, 6 or dietary elimination 7-9) and moderate to severe in nature, clinicians frequently prescribe systemic treatments, including monoclonal antibodies, small molecule immunosuppressants and immunomodulators such ...

3. onlinelibrary.wiley.com › doi › fullEuropean guideline (EuroGuiDerm) on atopic eczema: part I –...

   onlinelibrary.wiley.com › doi › full

   18 Αυγ 2022 · The systemic treatment options discussed in the guideline comprise conventional immunosuppressive drugs (azathioprine, ciclosporin, glucocorticosteroids, methotrexate and mycophenolate mofetil), biologics (dupilumab, lebrikizumab, nemolizumab, omalizumab and tralokinumab) and janus kinase inhibitors (abrocitinib, baricitinib and upadacitinib).

4. pubmed.ncbi.nlm.nih.gov › 35980214European guideline (EuroGuiDerm) on atopic eczema: part I -...

   pubmed.ncbi.nlm.nih.gov › 35980214

   The systemic treatment options discussed in the guideline comprise conventional immunosuppressive drugs (azathioprine, ciclosporin, glucocorticosteroids, methotrexate and mycophenolate mofetil), biologics (dupilumab, lebrikizumab, nemolizumab, omalizumab and tralokinumab) and janus kinase inhibitors (abrocitinib, baricitinib and upadacitinib).

5. pmc.ncbi.nlm.nih.gov › articles › PMC6357995Novel systemic therapies in atopic dermatitis: what do we need to...

   pmc.ncbi.nlm.nih.gov › articles › PMC6357995

   Patients with atopic dermatitis (AD) who do not adequately respond to topical therapy and phototherapy often need systemic immunomodulatory treatment to control their symptoms. Conventional systemic agents, such as ciclosporin, azathioprine, and ...

6. jamanetwork.com › journals › jamadermatologySystemic Immunomodulatory Treatments for Atopic Dermatitis

   jamanetwork.com › journals › jamadermatology

   • Αποθηκευμένο αντίγραφο

   In our updated living systematic review and network meta-analysis of systemic treatments for atopic dermatitis, the JAK inhibitors abrocitinib, baricitinib, and upadacitinib and the biologic tralokinumab were associated with improved index scores compared with placebo in randomized clinical trials and were associated with comparable ...

7. onlinelibrary.wiley.com › doi › 10Systemic treatments in the management of atopic dermatitis: A ...

   onlinelibrary.wiley.com › doi › 10

   19 Οκτ 2020 · As an evidence resource for the currently planned European Academy of Allergy and Clinical Immunology (EAACI) clinical practice guideline “systemic treatment of atopic dermatitis (AD),” we critically appraised evidence on systemic treatments for moderate-to-severe AD. Methods.